Precision Therapeutics (NASDAQ:POAI) Stock Price Crosses Above 50 Day Moving Average of $0.00

Precision Therapeutics Inc (NASDAQ:POAI) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.65. Precision Therapeutics shares last traded at $0.61, with a volume of 5,676 shares trading hands.

The company has a debt-to-equity ratio of 3.68, a current ratio of 0.77 and a quick ratio of 0.71.

Precision Therapeutics (NASDAQ:POAI) last released its quarterly earnings data on Wednesday, May 15th. The medical instruments supplier reported ($0.21) earnings per share (EPS) for the quarter. Precision Therapeutics had a negative net margin of 925.08% and a negative return on equity of 714.98%. The company had revenue of $0.26 million during the quarter.

In related news, CEO Carl I. Schwartz acquired 100,000 shares of the firm’s stock in a transaction on Friday, May 24th. The stock was bought at an average price of $0.56 per share, for a total transaction of $56,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 13.38% of the company’s stock.

About Precision Therapeutics (NASDAQ:POAI)

Predictive Oncology Inc provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables.

Featured Story: What is an economic bubble?

Receive News & Ratings for Precision Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.